BIRR IVF Labware is developed and produced according to the highest quality standards. All our qualitative tests are performed in a state-of-the-art laboratory, which strives for continuous improvement on testing reliability and accuracy. This enables BIRR to ensure that labware products are safe and performant.


BIRR IVF labware certification and testing standards Dishes Tubes Containers Pipettes Other labware
CE IIa medical device
FDA clearance
ISO 13485:2016 certified
MEA (+) test √+
LAL test
SMA test
Produced in EU



BIRR IVF labware is registered in several countries in Europe, North-America, South-America and Asia.
When required, local regulatory registration will be established. For information about specific geographies, please reach out to us.

BIRR introduces its smART Labware label:

BIRR IVF labware with innovative feature and added value on ease of use or safety versus conventional labware

BIRR IVF Labware certification standards

BIRR IVF Labware is also certified according to the highest standards.

All BIRR IVF labware products are Medical Devices: they are certified CE Class IIa sterile Medical Devices in accordance with 93/42 EEC Directive. Medical devices (MD) are intended and tested for direct or indirect use with a human body (e.g., in vivo and in vitro).

CE IIa marking indicates that the product meets the highest safety, health and environmental requirements set by the European Union. In Europe and other geographies, CE IIa marking is compulsory for products used in IVF treatments.

Different from Medical Devices, in Vitro Diagnostics devices (IVD) are intended and approved for use in testing of human samples, where the results can assist in clinical diagnosis. Thus IVD-products are for diagnostic purposes only, NOT for clinical use.

BIRR IVF Labware testing standards

Why does BIRR have a robust testing program of it’s IVF labware portfolio? MEA, LAL and SMA tests are performed to detect whether the ma- terials and processes employed in labware manufacturing affect gametes viability or embryo development. Successful testing ensures undeviating labware performance that doesn’t interfere with specimens’ biological processes. Lack of product quality assurance through each of these tests may compromise labware consistency, ultimately affecting laboratory and clinical outcomes. BIRR’s robust quality assurance program ensures that- labware standards are persistently mantained, providing laboratories the stability required for reliable gamete and embryo culture performance.

Test carried out on each product LOT:

Mouse Embryo Assay (MEA): Across the labware portfolio, two different type of MEA tests are performed, the Standard MEA or Extended MEA

  • The Standard MEA is performed on the labware that has contact time<24 hours with gametes or embryos (e.g., tubes, pipettes). This approach involves the exposure of culture media to the tested labware for 2 hours. This media is then used for incubation of 1-cell mouse embryos (n-21, Test group) until Day 5 of development in a reference dish. In parallel, 1-cell mouse embryos (n=15, Control group) are cultured in the same type of reference culture dish using media that was not exposed to the testing labware. For each group, embryo cleavage is assessed at 24hrs and blastocyst formation is assessed at 96hrs (Day 5 development). A product lot is accepted when testing outcomes show blastocyst formation rate > 80% in the Test group.
  • The Extended MEA (MEA+) is performed on labware that has a contact time>24 hours, done for all dishes (i.e., dishes). This approach involves continued exposure of 1-cell mouse embryos (n=21, Test group) to the tested labware throughout a 96hrs culture period (Day 5 of develop- ment). In parallel, 1-cell mouse embryos (n=15, Control group) are cultured in the same type of reference culture dish using media that was not exposed to the testing labware. For each group, embryo cleavage is assessed at 24hrs and blastocyst formation is assessed at 96hrs (Day 5 de- velopment). A product lot is accepted when testing outcomes show blastocyst formation rate > 80% in the Test group.

Sperm Motility Assay (SMA) test: Good quality post-preparation sperm samples are exposed to the testing labware (Experimental group) or left in the reference labware (Control group) for 8 hours. The ratio between sperm motility rate from the Experimental and Control groups determines sperm motility index (SMI). Product lot acceptance threshold is set at SMI >0.75.

Limulus Amebocyte Lysate (LAL) test: Presence of bacterial endotoxin lipopolysaccharide (LPS) is tested through LAL test on all labware. Acceptance detection threshold < 0.03EU/device.

Results of quality test are available upon request for each LOT number.